COMMUNIQUÉ DE PRESSE publié le 17/01/2024 à 08:00, il y a 2 années 5 mois Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Publié le 08/07/2026 à 18:00, il y a 13 minutes 464 M€ DE NOUVEAUX FINANCEMENTS POUR SOUTENIR LA CROISSANCE DE FREY
Publié le 08/07/2026 à 18:00, il y a 13 minutes €464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH
Publié le 08/07/2026 à 17:45, il y a 28 minutes COGRA : CHIFFRE D’AFFAIRES DE L'EXERCICE 2025/26 : 42,4 M€ +24%
Publié le 08/07/2026 à 15:25, il y a 2 heures 48 minutes Rockhaven Announces Granting of Incentive Stock Options
Publié le 08/07/2026 à 15:00, il y a 3 heures 13 minutes Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Publié le 08/07/2026 à 15:00, il y a 3 heures 13 minutes GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Publié le 08/07/2026 à 14:30, il y a 3 heures 43 minutes Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily
Publié le 08/07/2026 à 18:03, il y a 9 minutes Kontron AG: The Executive Board and Supervisory Board recommend that shareholders do not accept the mandatory takeover offer from Ennoconn Corporation
Publié le 08/07/2026 à 15:42, il y a 2 heures 30 minutes EQS-Adhoc: Kapsch TrafficCom signs agreement on the sale of a majority stake in German subsidiary and is therefore expecting a significant impact on EBIT.
Publié le 08/07/2026 à 15:22, il y a 2 heures 50 minutes Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Publié le 08/07/2026 à 15:21, il y a 2 heures 51 minutes Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Publié le 08/07/2026 à 15:21, il y a 2 heures 51 minutes Form 8.3 - The Vanguard Group, Inc.: Senior plc